Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 22, 2020 Filed May 27, 2020 17:08 UTC |
Kraws Jeffrey JCo-President
|
PurchaseCommon Stock | 10,000 | $0.46 | $4,600.00 |
DisclosureSEC source: 0001209191-20-032338 · doc4.xml · nonDerivative · entry 1 Kraws Jeffrey J · CIK 0001380918 · Co-President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,339 Read SEC document |
| May 22, 2020 Filed May 27, 2020 21:12 UTC |
Horwood DanielGeneral Counsel
|
PurchaseCommon Stock | 10,000 | $0.47 | $4,650.00 |
DisclosureSEC source: 0001209191-20-032341 · doc4.xml · nonDerivative · entry 1 Horwood Daniel · CIK 0001756566 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,641 Read SEC document |
| May 20, 2020 Filed May 22, 2020 21:17 UTC | GrantCommon Stock | 5,000 | $0.42 | $2,112.50 |
DisclosureSEC source: 0001209191-20-031833 · doc4.xml · nonDerivative · entry 1 Jackson Andrew C. · CIK 0001636738 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,202 F1 · shares: These shares were acquired on May 20, 2020 through the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
|
| May 20, 2020 Filed May 22, 2020 21:14 UTC |
Horwood DanielGeneral Counsel
|
GrantCommon Stock | 5,000 | $0.42 | $2,112.50 |
DisclosureSEC source: 0001209191-20-031827 · doc4.xml · nonDerivative · entry 1 Horwood Daniel · CIK 0001756566 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,641 F1 · shares: These shares were acquired on May 20, 2020 through the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| April 28, 2020 Filed Apr 29, 2020 16:56 UTC |
Irwin Dean10% owner
Burstein Melissa10% owner
|
SaleRMED | 60,000 | $1.07 | $64,014.00 |
DisclosureSEC source: 0001746687-20-000003 · primary_doc.xml · nonDerivative · entry 3 Irwin Dean · CIK 0001746687 · 10% owner Burstein Melissa · CIK 0001746295 · 10% owner Dean Irwin & Melissa Burstein, as Trustees U/T/A June 12, 2017 · CIK 0001748379 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,743,852 F2 · price: The reported price is a weighted average sale price. These shares were sold in multiple transactions at different prices. The Reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. F3 · ownership.nature: Shares held of record by Dean Irwin and Melissa Burstein, as trustees U/T/A June 12, 2017, of which Dean Irwin serves as co-trustee Read SEC document |
| April 27, 2020 Filed Apr 29, 2020 16:56 UTC |
Irwin Dean10% owner
Burstein Melissa10% owner
|
SaleRMED | 26,400 | $1.03 | $27,181.44 |
DisclosureSEC source: 0001746687-20-000003 · primary_doc.xml · nonDerivative · entry 2 Irwin Dean · CIK 0001746687 · 10% owner Burstein Melissa · CIK 0001746295 · 10% owner Dean Irwin & Melissa Burstein, as Trustees U/T/A June 12, 2017 · CIK 0001748379 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 28,697 F1 · shares: The sales reported were pursuant to Rule 10b5-1 trading plans adopted by the reporting person and the reporting person's spouse on Sept. 27, 2018. F2 · price: The reported price is a weighted average sale price. These shares were sold in multiple transactions at different prices. The Reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| April 27, 2020 Filed Apr 29, 2020 16:56 UTC |
Irwin Dean10% owner
Burstein Melissa10% owner
|
SaleRMED | 44,400 | $1.03 | $45,621.00 |
DisclosureSEC source: 0001746687-20-000003 · primary_doc.xml · nonDerivative · entry 1 Irwin Dean · CIK 0001746687 · 10% owner Burstein Melissa · CIK 0001746295 · 10% owner Dean Irwin & Melissa Burstein, as Trustees U/T/A June 12, 2017 · CIK 0001748379 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,652 F1 · shares: The sales reported were pursuant to Rule 10b5-1 trading plans adopted by the reporting person and the reporting person's spouse on Sept. 27, 2018. F2 · price: The reported price is a weighted average sale price. These shares were sold in multiple transactions at different prices. The Reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| April 27, 2020 Filed Apr 29, 2020 09:04 UTC |
Stafslien JoanDirector
|
GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-026094 · doc4.xml · nonDerivative · entry 1 Stafslien Joan · CIK 0001467816 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 F1 · shares: Reported shares are represented by restricted stock units ("RSUs"), and each RSU is the economic equivalent of one share of Ra Medical Systems, Inc. common stock. Beginning on April 24, 2021, 1/3 of the RSUs shall vest annually, so that the RSUs will be fully vested on April 24, 2023, subject to the reporting person's continued service through each such vesting date. Read SEC document |
| March 30, 2020 Filed Apr 1, 2020 17:56 UTC |
McGuire Jonathan WillDirector · Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 450,000 | $0.00 Strike: $1.02 | $0.00 |
DisclosureSEC source: 0001209191-20-022225 · doc4.xml · derivative · entry 2 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,000 Underlying: Common Stock · 450,000 shares Expires 2030-03-30 F2 · derivative.exercise_date: The option shall vest in equal monthly installments over four years following March 30, 2020, subject to the reporting person continuing to be a Service Provider (as defined in the Company's 2020 Inducement Equity Incentive Plan) to the Company through each vesting date, so that the option is fully vested on March 30, 2024. Read SEC document |
| March 30, 2020 Filed Apr 1, 2020 17:56 UTC |
McGuire Jonathan WillDirector · Chief Executive Officer
|
GrantCommon Stock | 125,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-022225 · doc4.xml · nonDerivative · entry 1 McGuire Jonathan Will · CIK 0001345539 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 F1 · shares: The reported shares were issued as a restricted stock award ("RSA"). The RSA shall vest and become non-forfeitable in equal semi-annual installments over four years following May 20, 2020, subject to the reporting person continuing to be a Service Provider (as defined in the Company's 2020 Inducement Equity Incentive Plan) through each vesting date (for the avoidance of doubt, the first vesting date for the RSA will be November 20, 2020, upon which date 1/8 of the shares covered by the RSA may vest). Read SEC document |
| January 22, 2020 Filed Jan 25, 2020 00:55 UTC |
Irwin Dean10% owner
|
Salecommon stock | 7,700 | $1.89 | $14,569.17 |
DisclosureSEC source: 0001746687-20-000002 · primary_doc.xml · nonDerivative · entry 6 Irwin Dean · CIK 0001746687 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 55,097 F2 · shares: The sales reported were effected pursuant to Rule 10b5-1 trading plans adopted by the reporting person and the reporting person's spouse on Sept. 27, 2018 F5 · price: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at different prices. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 22, 2020 Filed Jan 25, 2020 00:55 UTC |
Irwin Dean10% owner
|
Salecommon stock | 12,950 | $1.89 | $24,498.81 |
DisclosureSEC source: 0001746687-20-000002 · primary_doc.xml · nonDerivative · entry 5 Irwin Dean · CIK 0001746687 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,052 F2 · shares: The sales reported were effected pursuant to Rule 10b5-1 trading plans adopted by the reporting person and the reporting person's spouse on Sept. 27, 2018 F5 · price: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at different prices. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 06, 2020 Filed Jan 8, 2020 17:38 UTC |
ENQUIST WILLIAM RDirector
|
GrantStock Option (Right to Buy) · Derivative | 43,644 | $0.00 Strike: $1.18 | $0.00 |
DisclosureSEC source: 0001209191-20-002577 · doc4.xml · derivative · entry 1 ENQUIST WILLIAM R · CIK 0001659002 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,644 Underlying: Common Stock · 43,644 shares Expires 2030-01-06 F1 · derivative.exercise_date: The Reporting Person has elected to receive his 2020 retainer compensation in stock option grants, rather than cash. Subject to the Reporting Person continuing to be a "Service Provider" (as defined in the Company's 2018 Equity Incentive Plan) through each vesting date, the shares shall vest as follows: 25% of the shares subject to the option shall vest quarterly on the fifth of the month immediately following the end of the quarter corresponding with the date of grant (i.e. April 5, 2020, July 5, 2020, October 5, 2020, and January 5, 2021), such that the shares shall be fully vested on January 5, 2021. Read SEC document |
| January 06, 2020 Filed Jan 8, 2020 17:41 UTC |
Mejia Richard JrDirector
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $1.18 | $0.00 |
DisclosureSEC source: 0001209191-20-002580 · doc4.xml · derivative · entry 1 Mejia Richard Jr · CIK 0001445578 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-01-06 F1 · derivative.exercise_date: The Reporting Person has elected to receive his 2020 retainer compensation in stock option grants, rather than cash. Subject to the Reporting Person continuing to be a "Service Provider" (as defined in the Company's 2018 Equity Incentive Plan) through each vesting date, the shares shall vest as follows: 25% of the shares subject to the option shall vest quarterly on the fifth of the month immediately following the end of the quarter corresponding with the date of grant (i.e. April 5, 2020, July 5, 2020, October 5, 2020, and January 5, 2021), such that the shares shall be fully vested on January 5, 2021. Read SEC document |
| January 06, 2020 Filed Jan 8, 2020 17:35 UTC |
COLOMBATTO MARTIN JDirector
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $1.18 | $0.00 |
DisclosureSEC source: 0001209191-20-002575 · doc4.xml · derivative · entry 1 COLOMBATTO MARTIN J · CIK 0001208236 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-01-06 F1 · derivative.exercise_date: The Reporting Person has elected to receive his 2020 retainer compensation in stock option grants, rather than cash. Subject to the Reporting Person continuing to be a "Service Provider" (as defined in the Company's 2018 Equity Incentive Plan) through each vesting date, the shares shall vest as follows: 25% of the shares subject to the option shall vest quarterly on the fifth of the month immediately following the end of the quarter corresponding with the date of grant (i.e. April 5, 2020, July 5, 2020, October 5, 2020, and January 5, 2021), such that the shares shall be fully vested on January 5, 2021. Read SEC document |
| January 06, 2020 Filed Jan 8, 2020 22:44 UTC |
Saad Mark EDirector
|
GrantStock Option (Right to Buy) · Derivative | 49,576 | $0.00 Strike: $1.18 | $0.00 |
DisclosureSEC source: 0001209191-20-002586 · doc4.xml · derivative · entry 1 Saad Mark E · CIK 0001295913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,576 Underlying: Common Stock · 49,576 shares Expires 2030-01-06 F1 · derivative.exercise_date: The Reporting Person has elected to receive his 2020 retainer compensation in stock option grants, rather than cash. Subject to the Reporting Person continuing to be a "Service Provider" (as defined in the Company's 2018 Equity Incentive Plan) through each vesting date, the shares shall vest as follows: 25% of the shares subject to the option shall vest quarterly on the fifth of the month immediately following the end of the quarter corresponding with the date of grant (i.e. April 5, 2020, July 5, 2020, October 5, 2020, and January 5, 2021), such that the shares shall be fully vested on January 5, 2021. Read SEC document |
| December 20, 2019 Filed Dec 26, 2019 21:04 UTC |
Jackson Andrew C.CFO & Interim CEO
|
Tax withholdingCommon Stock | 4,641 | $0.90 | $4,181.54 |
DisclosureSEC source: 0001209191-19-061916 · doc4.xml · nonDerivative · entry 1 Jackson Andrew C. · CIK 0001636738 · CFO & Interim CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,202 F1 · kind: Shares withheld by the issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units. This is not an open market sale of securities. Read SEC document |
| December 20, 2019 Filed Dec 26, 2019 16:06 UTC |
Kraws Jeffrey JCo-President
|
Tax withholdingCommon Stock | 792 | $0.90 | $713.59 |
DisclosureSEC source: 0001209191-19-061922 · doc4.xml · nonDerivative · entry 1 Kraws Jeffrey J · CIK 0001380918 · Co-President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 113,339 F1 · kind: Shares withheld by the issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units. This is not an open market sale of securities. Read SEC document |
| December 17, 2019 Filed Dec 18, 2019 16:58 UTC |
Burstein Martin10% owner
|
SaleCommon Stock | 4,448 | $0.75 | $3,336.00 |
DisclosureSEC source: 0001493152-19-019411 · ownership.xml · nonDerivative · entry 2 Burstein Martin · CIK 0001748671 · 10% owner Martin Burstein Living Trust Dated January 28, 2002 · CIK 0001748362 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,606,203 F3 · price: The price reported is a weighted average. These shares were sold in multiple transactions at prices ranging from not less than $0.75 to not more than $0.76. F2 · ownership.nature: Shares held of record by a family trust of which Martin Burstein is the sole trustee. Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 16:58 UTC |
Burstein Martin10% owner
|
SaleCommon Stock | 22,436 | $0.75 | $16,827.00 |
DisclosureSEC source: 0001493152-19-019411 · ownership.xml · nonDerivative · entry 1 Burstein Martin · CIK 0001748671 · 10% owner Martin Burstein Living Trust Dated January 28, 2002 · CIK 0001748362 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,610,651 F1 · price: The price reported is a weighted average. These shares were sold in multiple transactions at prices ranging from not less than $0.75 to not more than $0.80. The reporting person undertakes to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the ranges set forth in the footnotes to this Form 4 that report a range of prices. F2 · ownership.nature: Shares held of record by a family trust of which Martin Burstein is the sole trustee. Read SEC document |
| December 13, 2019 Filed Dec 16, 2019 17:09 UTC |
Burstein Martin10% owner
|
SaleCommon Stock | 20,000 | $0.84 | $16,800.00 |
DisclosureSEC source: 0001493152-19-019303 · ownership.xml · nonDerivative · entry 2 Burstein Martin · CIK 0001748671 · 10% owner Martin Burstein Living Trust Dated January 28, 2002 · CIK 0001748362 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,633,087 F3 · price: The price reported is a weighted average. These shares were sold in multiple transactions at prices ranging from not less than $0.80 to not more than $0.91. F2 · ownership.nature: Shares held of record by a family trust of which Martin Burstein is the sole trustee. Read SEC document |
| December 12, 2019 Filed Dec 16, 2019 17:09 UTC |
Burstein Martin10% owner
|
SaleCommon Stock | 6,100 | $0.87 | $5,307.00 |
DisclosureSEC source: 0001493152-19-019303 · ownership.xml · nonDerivative · entry 1 Burstein Martin · CIK 0001748671 · 10% owner Martin Burstein Living Trust Dated January 28, 2002 · CIK 0001748362 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,653,087 F1 · price: The price reported is a weighted average. These shares were sold in multiple transactions at prices ranging from not less than $0.87 to not more than $0.89. The reporting person undertakes to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the shares sold at each separate price within the ranges set forth in the footnotes to this Form 4 that report a range of prices. F2 · ownership.nature: Shares held of record by a family trust of which Martin Burstein is the sole trustee. Read SEC document |
| December 10, 2019 Filed Dec 10, 2019 21:14 UTC |
Burstein Martin10% owner
|
SaleCommon Stock | 46,820 | $1.01 | $47,288.20 |
DisclosureSEC source: 0001493152-19-019003 · ownership.xml · nonDerivative · entry 7 Burstein Martin · CIK 0001748671 · 10% owner Martin Burstein Living Trust Dated January 28, 2002 · CIK 0001748362 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,659,187 F3 · ownership.nature: Shares held of record by the Burstein Trust. Read SEC document |
| December 10, 2019 Filed Dec 10, 2019 21:14 UTC |
Burstein Martin10% owner
|
OtherCommon Stock | 54,687 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-19-019003 · ownership.xml · nonDerivative · entry 6 Burstein Martin · CIK 0001748671 · 10% owner Martin Burstein Living Trust Dated January 28, 2002 · CIK 0001748362 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,706,007 F1 · shares: Represents transfer of shares for no consideration from Martin Burstein to a family trust (the "Burstein Trust") of which Martin Burstein is the sole trustee. F3 · ownership.nature: Shares held of record by the Burstein Trust. Read SEC document |
| December 10, 2019 Filed Dec 10, 2019 21:14 UTC |
Burstein Martin10% owner
|
OtherCommon Stock | 54,687 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-19-019003 · ownership.xml · nonDerivative · entry 5 Burstein Martin · CIK 0001748671 · 10% owner Martin Burstein Living Trust Dated January 28, 2002 · CIK 0001748362 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: Represents transfer of shares for no consideration from Martin Burstein to a family trust (the "Burstein Trust") of which Martin Burstein is the sole trustee. Read SEC document |
| December 09, 2019 Filed Dec 10, 2019 21:14 UTC |
Burstein Martin10% owner
|
SaleCommon Stock | 28,988 | $1.06 | $30,727.28 |
DisclosureSEC source: 0001493152-19-019003 · ownership.xml · nonDerivative · entry 4 Burstein Martin · CIK 0001748671 · 10% owner Martin Burstein Living Trust Dated January 28, 2002 · CIK 0001748362 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,651,320 F3 · ownership.nature: Shares held of record by the Burstein Trust. Read SEC document |
| December 06, 2019 Filed Dec 10, 2019 21:14 UTC |
Burstein Martin10% owner
|
SaleCommon Stock | 1,208 | $1.27 | $1,534.16 |
DisclosureSEC source: 0001493152-19-019003 · ownership.xml · nonDerivative · entry 3 Burstein Martin · CIK 0001748671 · 10% owner Martin Burstein Living Trust Dated January 28, 2002 · CIK 0001748362 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,680,308 F3 · ownership.nature: Shares held of record by the Burstein Trust. Read SEC document |
| December 04, 2019 Filed Dec 5, 2019 23:20 UTC |
Jackson Andrew C.CFO & Interim CEO
|
Tax withholdingCommon Stock | 4,505 | $1.69 | $7,613.45 |
DisclosureSEC source: 0001209191-19-059368 · doc4.xml · nonDerivative · entry 1 Jackson Andrew C. · CIK 0001636738 · CFO & Interim CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,843 F1 · kind: Shares withheld by the issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units. This is not an open market sale of securities. F2 · balance_after: Of the reported shares 13,424 shares are represented by Restricted Stock Units. Read SEC document |
| December 04, 2019 Filed Dec 5, 2019 18:23 UTC |
Kraws Jeffrey JCo-President
|
Tax withholdingCommon Stock | 38,372 | $1.82 | $69,909.95 |
DisclosureSEC source: 0001209191-19-059371 · doc4.xml · nonDerivative · entry 1 Kraws Jeffrey J · CIK 0001380918 · Co-President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,131 F1 · kind: Shares withheld by the issuer to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units. This is not an open market sale of securities. F2 · price: Represents the weighted share price of an aggregate total of 38,372 shares withheld in the price range of $1.69 to $1.96 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares withheld at each separate price. F3 · balance_after: Of the reported shares 2,315 shares are represented by Restricted Stock Units. Read SEC document |
| December 04, 2019 Filed Jan 25, 2020 00:55 UTC |
Irwin Dean10% owner
|
Tax withholdingcommon stock | 15,442 | $1.96 | $30,266.32 |
DisclosureSEC source: 0001746687-20-000002 · primary_doc.xml · nonDerivative · entry 4 Irwin Dean · CIK 0001746687 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 62,797 F1 · date: Filed manually with the SEC pursuit to hardship on 12/06/2019 F3 · shares: Represents the number of shares required to be sold by the reporting persons to cover tax witholding obligations in connection with the vesting of restricted stock units. The sale is mandated by the reporting person's award agreement to require the satisfaction of tax witholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| December 04, 2019 Filed Jan 25, 2020 00:55 UTC |
Irwin Dean10% owner
|
Tax withholdingcommon stock | 12,868 | $1.96 | $25,221.28 |
DisclosureSEC source: 0001746687-20-000002 · primary_doc.xml · nonDerivative · entry 3 Irwin Dean · CIK 0001746687 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,002 F1 · date: Filed manually with the SEC pursuit to hardship on 12/06/2019 F3 · shares: Represents the number of shares required to be sold by the reporting persons to cover tax witholding obligations in connection with the vesting of restricted stock units. The sale is mandated by the reporting person's award agreement to require the satisfaction of tax witholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. Read SEC document |
| December 04, 2019 Filed Jan 25, 2020 00:55 UTC |
Irwin Dean10% owner
|
Salecommon stock | 4,400 | $1.19 | $5,215.32 |
DisclosureSEC source: 0001746687-20-000002 · primary_doc.xml · nonDerivative · entry 2 Irwin Dean · CIK 0001746687 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 78,239 F1 · date: Filed manually with the SEC pursuit to hardship on 12/06/2019 F2 · shares: The sales reported were effected pursuant to Rule 10b5-1 trading plans adopted by the reporting person and the reporting person's spouse on Sept. 27, 2018 F5 · price: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at different prices. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 04, 2019 Filed Jan 25, 2020 00:55 UTC |
Irwin Dean10% owner
|
Salecommon stock | 7,400 | $1.19 | $8,786.02 |
DisclosureSEC source: 0001746687-20-000002 · primary_doc.xml · nonDerivative · entry 1 Irwin Dean · CIK 0001746687 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,870 F1 · date: Filed manually with the SEC pursuit to hardship on 12/06/2019 F2 · shares: The sales reported were effected pursuant to Rule 10b5-1 trading plans adopted by the reporting person and the reporting person's spouse on Sept. 27, 2018 F5 · price: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at different prices. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 03, 2019 Filed Dec 5, 2019 23:20 UTC |
Jackson Andrew C.CFO & Interim CEO
|
GrantStock Option (Right to Buy) · Derivative | 139,052 | $0.00 Strike: $1.22 | $0.00 |
DisclosureSEC source: 0001209191-19-059368 · doc4.xml · derivative · entry 2 Jackson Andrew C. · CIK 0001636738 · CFO & Interim CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,052 Underlying: Common Stock · 139,052 shares Expires 2029-12-03 F3 · derivative.exercise_date: 1/12 of the total shares subject to the option shall vest every month after December 3, 2019, such that all shares subject to the option shall be fully vested on December 3, 2020, subject to the Reporting Person continuing to be a "Service Provider" (as defined in the Company's 2018 Equity Incentive Plan) through each vesting date. Read SEC document |
| December 03, 2019 Filed Dec 5, 2019 18:23 UTC |
Kraws Jeffrey JCo-President
|
GrantStock Option (Right to Buy) · Derivative | 139,052 | $0.00 Strike: $1.22 | $0.00 |
DisclosureSEC source: 0001209191-19-059371 · doc4.xml · derivative · entry 2 Kraws Jeffrey J · CIK 0001380918 · Co-President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,052 Underlying: Common Stock · 139,052 shares Expires 2029-12-03 F4 · derivative.exercise_date: 1/36 of the total shares subject to the option shall vest every month after December 3, 2019, such that all shares shall be fully vested on December 3, 2022, subject to the Reporting Person continuing to be a "Service Provider" (as defined in the Company's 2018 Equity Incentive Plan) through each vesting date. Read SEC document |
| December 03, 2019 Filed Dec 5, 2019 23:17 UTC |
Horwood DanielGeneral Counsel
|
GrantStock Option (Right to Buy) · Derivative | 139,052 | $0.00 Strike: $1.22 | $0.00 |
DisclosureSEC source: 0001209191-19-059366 · doc4.xml · derivative · entry 1 Horwood Daniel · CIK 0001756566 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,052 Underlying: Common Stock · 139,052 shares Expires 2029-12-03 F1 · derivative.exercise_date: 1/12 of the total shares subject to the option shall vest every month after December 3, 2019, such that all shares subject to the option shall be fully vested on December 3, 2020, subject to the Reporting Person continuing to be a "Service Provider" (as defined in the Company's 2018 Equity Incentive Plan) through each vesting date. Read SEC document |
| August 05, 2019 Filed Dec 10, 2019 21:14 UTC |
Burstein Martin10% owner
|
OtherCommon Stock | 77,016 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-19-019003 · ownership.xml · nonDerivative · entry 2 Burstein Martin · CIK 0001748671 · 10% owner Martin Burstein Living Trust Dated January 28, 2002 · CIK 0001748362 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 1,681,516 F1 · shares: Represents transfer of shares for no consideration from Martin Burstein to a family trust (the "Burstein Trust") of which Martin Burstein is the sole trustee. F3 · ownership.nature: Shares held of record by the Burstein Trust. Read SEC document |
| August 05, 2019 Filed Dec 10, 2019 21:14 UTC |
Burstein Martin10% owner
|
OtherCommon Stock | 77,016 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-19-019003 · ownership.xml · nonDerivative · entry 1 Burstein Martin · CIK 0001748671 · 10% owner Martin Burstein Living Trust Dated January 28, 2002 · CIK 0001748362 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,687 F1 · shares: Represents transfer of shares for no consideration from Martin Burstein to a family trust (the "Burstein Trust") of which Martin Burstein is the sole trustee. F2 · balance_after: 47,547 shares represented by restricted stock units held by Mr. Burstein were forfeited in connection with the termination of his consulting services to the issuer. Read SEC document |
| July 18, 2019 Filed Jul 22, 2019 17:32 UTC |
Irwin DeanDirector · See Remarks · 10% owner
|
SaleCommon Stock | 8,584 | $2.93 | $25,163.14 |
DisclosureSEC source: 0001209191-19-042894 · doc4.xml · nonDerivative · entry 2 Irwin Dean · CIK 0001746687 · Director · See Remarks · 10% owner Dean Irwin & Melissa Burstein, as Trustees U/T/A June 12, 2017 · CIK 0001748379 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 119,854 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Reporting Person's award agreement to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F3 · balance_after: Of the reported shares 81,873 shares are represented by Restricted Stock Units. Read SEC document |
| July 18, 2019 Filed Jul 22, 2019 17:32 UTC |
Irwin DeanDirector · See Remarks · 10% owner
|
SaleCommon Stock | 14,302 | $2.93 | $41,924.88 |
DisclosureSEC source: 0001209191-19-042894 · doc4.xml · nonDerivative · entry 1 Irwin Dean · CIK 0001746687 · Director · See Remarks · 10% owner Dean Irwin & Melissa Burstein, as Trustees U/T/A June 12, 2017 · CIK 0001748379 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,510 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Reporting Person's award agreement to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · balance_after: Of the reported shares 136,455 shares are represented by Restricted Stock Units. Read SEC document |
| July 18, 2019 Filed Jul 23, 2019 11:50 UTC |
Kraws Jeffrey JCo-President
|
SaleCommon Stock | 11,930 | $2.93 | $34,971.60 |
DisclosureSEC source: 0001209191-19-042949 · doc4.xml · nonDerivative · entry 1 Kraws Jeffrey J · CIK 0001380918 · Co-President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,503 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Reporting Person's award agreement to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · balance_after: Of the reported shares 92,384 shares are represented by Restricted Stock Units. Read SEC document |
| July 12, 2019 Filed Jul 16, 2019 18:05 UTC |
Irwin DeanDirector · See Remarks · 10% owner
|
SaleCommon Stock | 4,400 | $3.28 | $14,412.64 |
DisclosureSEC source: 0001209191-19-042266 · doc4.xml · nonDerivative · entry 2 Irwin Dean · CIK 0001746687 · Director · See Remarks · 10% owner Dean Irwin & Melissa Burstein, as Trustees U/T/A June 12, 2017 · CIK 0001748379 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 128,438 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plans adopted by the reporting person and the reporting person's spouse on September 27, 2018. F4 · price: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $3.06 to $3.35 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F5 · balance_after: Of the reported shares 104,202 shares are represented by Restricted Stock Units. Read SEC document |
| July 12, 2019 Filed Jul 16, 2019 18:05 UTC |
Irwin DeanDirector · See Remarks · 10% owner
|
SaleCommon Stock | 7,400 | $3.27 | $24,172.10 |
DisclosureSEC source: 0001209191-19-042266 · doc4.xml · nonDerivative · entry 1 Irwin Dean · CIK 0001746687 · Director · See Remarks · 10% owner Dean Irwin & Melissa Burstein, as Trustees U/T/A June 12, 2017 · CIK 0001748379 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 213,812 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plans adopted by the reporting person and the reporting person's spouse on September 27, 2018. F2 · price: The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $3.07 to $3.35 per share. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Of the reported shares 173,670 shares are represented by Restricted Stock Units. Read SEC document |
| June 13, 2019 Filed Jun 17, 2019 21:23 UTC | SaleCommon Stock | 5,134 | $3.08 | $15,793.72 |
DisclosureSEC source: 0001209191-19-037442 · doc4.xml · nonDerivative · entry 1 Jackson Andrew C. · CIK 0001636738 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,348 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Reporting Person's award agreement to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · balance_after: Of the reported shares 26,453 shares are represented by Restricted Stock Units. Read SEC document |
|
| June 13, 2019 Filed Jun 17, 2019 17:25 UTC |
Kraws Jeffrey JCo-President
|
SaleCommon Stock | 18,021 | $3.08 | $55,438.00 |
DisclosureSEC source: 0001209191-19-037452 · doc4.xml · nonDerivative · entry 1 Kraws Jeffrey J · CIK 0001380918 · Co-President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,433 F1 · shares: Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Reporting Person's award agreement to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person. F2 · balance_after: Of the reported shares 136,297 shares are represented by Restricted Stock Units. Read SEC document |
| June 06, 2019 Filed Jun 7, 2019 17:47 UTC |
ENQUIST WILLIAM RDirector
|
GrantCommon Stock | 29,850 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-035629 · doc4.xml · nonDerivative · entry 1 ENQUIST WILLIAM R · CIK 0001659002 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,085 F1 · shares: Reported shares represents a grant of restricted stock units (the "RSUs") pursuant to Ra Medical Systems, Inc.'s 2018 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Ra Medical Systems, Inc. common stock. The RSUs will vest on the earlier of (i) June 6, 2020, or (ii) the day prior to the date of the Annual Meeting next following June 6, 2019, subject to the reporting person's continued service. Read SEC document |
| June 06, 2019 Filed Jun 7, 2019 17:52 UTC |
Mejia Richard JrDirector
|
GrantCommon Stock | 29,850 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-035632 · doc4.xml · nonDerivative · entry 1 Mejia Richard Jr · CIK 0001445578 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,085 F1 · shares: Reported shares represents a grant of restricted stock units (the "RSUs") pursuant to Ra Medical Systems, Inc.'s 2018 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Ra Medical Systems, Inc. common stock. The RSUs will vest on the earlier of (i) June 6, 2020, or (ii) the day prior to the date of the Annual Meeting next following June 6, 2019, subject to the reporting person's continued service. Read SEC document |
| June 06, 2019 Filed Jun 7, 2019 21:55 UTC |
Saad Mark EDirector
|
GrantCommon Stock | 29,850 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-035637 · doc4.xml · nonDerivative · entry 1 Saad Mark E · CIK 0001295913 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,085 F1 · shares: Reported shares represents a grant of restricted stock units (the "RSUs") pursuant to Ra Medical Systems, Inc.'s 2018 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Ra Medical Systems, Inc. common stock. The RSUs will vest on the earlier of (i) June 6, 2020, or (ii) the day prior to the date of the Annual Meeting next following June 6, 2019, subject to the reporting person's continued service. Read SEC document |
| June 06, 2019 Filed Jun 7, 2019 17:42 UTC |
BUCHBINDER MAURICEDirector
|
GrantCommon Stock | 29,850 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-035622 · doc4.xml · nonDerivative · entry 1 BUCHBINDER MAURICE · CIK 0001270178 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,475 F1 · shares: Reported shares represents a grant of restricted stock units (the "RSUs") pursuant to Ra Medical Systems, Inc.'s 2018 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Ra Medical Systems, Inc. common stock. The RSUs will vest on the earlier of (i) June 6, 2020, or (ii) the day prior to the date of the Annual Meeting next following June 6, 2019, subject to the reporting person's continued service. Read SEC document |
| June 06, 2019 Filed Jun 7, 2019 17:44 UTC |
COLOMBATTO MARTIN JDirector
|
GrantCommon Stock | 29,850 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-035626 · doc4.xml · nonDerivative · entry 1 COLOMBATTO MARTIN J · CIK 0001208236 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,475 F1 · shares: Reported shares represents a grant of restricted stock units (the "RSUs") pursuant to Ra Medical Systems, Inc.'s 2018 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Ra Medical Systems, Inc. common stock. The RSUs will vest on the earlier of (i) June 6, 2020, or (ii) the day prior to the date of the Annual Meeting next following June 6, 2019, subject to the reporting person's continued service. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.